ABOUT AICORE
WHO WE ARE
Aicore is an European pharmaceutical company.
WHAT WE DO
We are focused on the development, manufacture, and distribution of medications, whose efficacy has been established owing to evidence-based practices.
PORTFOLIO
As of today, our portfolio comprises nine products in the medical branches of otolaryngology, allergology, gastroenterology, pediatrics, and gynecology.
GEOGRAPHY
We have production sites in six European countries, representative offices in seven European countries, and we continue to expand our presence across the continent.
DATE OF COMPANY REGISTRATION
2010
ADDRESS
Aicore LLP
Suite 4073, 43 Bedford Street
London
United Kingdom
WC2E 9HA
aicore-info@aicore.eu
Tel. +44 20 3287 5635
Aicore is an European pharmaceutical company.
WHAT WE DO
We are focused on the development, manufacture, and distribution of medications, whose efficacy has been established owing to evidence-based practices.
PORTFOLIO
As of today, our portfolio comprises nine products in the medical branches of otolaryngology, allergology, gastroenterology, pediatrics, and gynecology.
GEOGRAPHY
We have production sites in six European countries, representative offices in seven European countries, and we continue to expand our presence across the continent.
DATE OF COMPANY REGISTRATION
2010
ADDRESS
Aicore LLP
Suite 4073, 43 Bedford Street
London
United Kingdom
WC2E 9HA
aicore-info@aicore.eu
Tel. +44 20 3287 5635
Aicore is a Europe-based pharma company with great potential for global growth. This map shows our current production sites, R&D sites, and representative offices in different countries. It also relays our plans for further expansion.
Production sites
Currently: Malta, Bulgaria, Italy, Greece, Belgium, Sweden
R&D sites
Netherlands
Representative offices
Currently: Netherlands, Romania, Bulgaria, Serbia, Croatia, Ukraine, Moldova
Planned: Poland, Albania, Montenegro, Macedonia, Bosnia & Herzegovina, Slovenia – from 2022
Greece – from 2023
Production sites
Currently: Malta, Bulgaria, Italy, Greece, Belgium, Sweden
R&D sites
Netherlands
Representative offices
Currently: Netherlands, Romania, Bulgaria, Serbia, Croatia, Ukraine, Moldova
Planned: Poland, Albania, Montenegro, Macedonia, Bosnia & Herzegovina, Slovenia – from 2022
Greece – from 2023
GLOBAL LOCATIONS
We want to provide you with the best possible, relevant experience on this site and use cookies and other technologies to understand your interests, customize your visit and manage our advertising. We respect your privacy and invite you to review our full Privacy Policy (including a detailed description of how we use cookies).
Agree, don't show this again
